European Journal of Nutrition

, Volume 58, Issue 2, pp 765–774 | Cite as

The effect of Guarana (Paullinia cupana) on metabolic and inflammatory parameters in adult male mice programmed by maternal obesity

  • Natália da Silva LimaEmail author
  • Cíntia Rabelo e Paiva Caria
  • Alessandra Gambero
  • Marcelo Lima RibeiroEmail author
Original Contribution



Maternal obesity can program the offspring, increasing the risk of overweight and obesity in adult life. Guarana (Paullinia cupana) is a Brazilian plant that has weight-reducing effects. Thus, this study aimed to evaluate the effects of Guarana on metabolic and inflammatory parameters in mice programmed by maternal obesity.


Swiss female mice were divided into two groups: control and high fat (HF), who received a standard diet or a high-fat diet (HFD), respectively, for 8 weeks prior to mating, gestation, and lactation. After post-natal day (PN) 21, the offspring of the HF group were subdivided into three groups: HF without treatment; HF early treatment, offspring treated with Guarana (1 g/kg bodyweight) in PN25–PN30; HF late treatment, offspring treated with Guarana (1 g/kg bodyweight) in PN65–PN75. Basal energy expenditure, the lipid profile and fasting glucose levels were determined. Body composition was evaluated by dissecting adipose tissue depots. Gene expression was analyzed using real-time PCR.


During mating, the weight of HF females increased; after lactation, their adipose tissue depots and fasting glycemic levels also increased. The offspring of the HF group showed an increased body weight at PN21. At PN80, in the mice treated with Guarana (with both treatments), VO2 and energy expenditure increased, adipose tissue depots decreased, and the expression of leptin, IL-6, TNF-α, and MCP-1 decreased compared with that in the HF group.


Guarana treatment at both stages of life reversed some of the alterations developed by the offspring of HF animals in adult life.


Maternal obesity Metabolic programming Guarana (Paullinia cupanaObesity Inflammation 


Compliance with ethical standards

Conflict of interest

All authors declare that there is no conflict of interest.


  1. 1.
    World Health Organization (2014) Overweight and obesity. Accessed 18 Dec 2017
  2. 2.
    CDC (2015) Vital signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among hispanics in the United States—2009–2013. Accessed 18 Dec 2017
  3. 3.
    Barker DJ (2003) The developmental origins of adult disease. Eur J Epidemiol 18:733–736CrossRefGoogle Scholar
  4. 4.
    de Moura EG, Passos MC (2005) Neonatal programming of body weight regulation and energetic metabolism. Biosci Rep 25(3–4):251–269CrossRefGoogle Scholar
  5. 5.
    Gluckman PD, Hanson MA (2007) Developmental plasticity and human disease: research directions. J Intern Med 261(5):461–471CrossRefGoogle Scholar
  6. 6.
    Ogden CL et al (2012) Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief (82):1–8.
  7. 7.
    Tan HC, Roberts J, Catov J, Krishnamurthy R, Shypailo R, Bacha F (2015) Mother’s pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood. Pediatr Diabetes 16(6):419–426. CrossRefGoogle Scholar
  8. 8.
    Ornellas F, Souza-Mello V, Mandarim-de-Lacerda CA, Aguila MB (2015) Programming of obesity and comorbidities in the progeny: lessons from a model of diet-induced obese parents. PLoS One 10(4):e0124737. CrossRefGoogle Scholar
  9. 9.
    Franco JG, Fernandes TP, Rocha CP, Calviño C, Pazos-Moura CC, Lisboa PC, Moura EG, Trevenzoli IH (2012) Maternal high-fat diet induces obesity and adrenal and thyroid dysfunction in male rat offspring at weaning. J Physiol 590:5503–5518. CrossRefGoogle Scholar
  10. 10.
    Belliardo F, Martelli A, Valle MG (1985) HPLC determination of caffeine and theophylline in Paullinia cupana Kunth (Guaraná) and Cola spp. samples. Z Lebensm Unters Forsch 1180:398–401CrossRefGoogle Scholar
  11. 11.
    Krewer C, Ribeiro C, Ribeiro EE, Moresco EA, da Rocha RN, Montagner MI, Machado GF, Viegas MM, Brito K, da Cruz EIB (2011) Habitual intake of Guarana and metabolic morbidities: an epidemiological study of an elderly Amazonian population. Phytother Res 25(9):1367–1374. Google Scholar
  12. 12.
    Harrold JA, Hughes GM, O’Shiel K, Quinn E, Boyland EJ, Williams NJ, Halford JC (2013) Acute effects of a herb extract formulation and inulin fibre on appetite, energy intake and food choice. Appetite 62:84–90. CrossRefGoogle Scholar
  13. 13.
    Santos JC, Gotardo EM, Brianti MT, Piraee M, Gambero A, Ribeiro ML (2014) Effects of yerba maté, a plant extract formulation (“YGD”) and resveratrol in 3T3-L1 adipogenesis. Molecules 19(10):16909–16924. CrossRefGoogle Scholar
  14. 14.
    Lima NS, Numata EP, Mesquita LMS, Dias PH, Vilegas W, Gambero A, Ribeiro ML (2017) Modulatory effects of Guarana (Paullinia cupana) on adipogenesis. Nutrients 9(6):E635. CrossRefGoogle Scholar
  15. 15.
    Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM et al (2008) New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454:1000–1004. CrossRefGoogle Scholar
  16. 16.
    Acedo SC, Caria CR, Gotardo EM, Pereira JA, Pedrazzoli J, Ribeiro ML, Gambero A (2015) Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice. World J Hepatol 7:2551–2558. CrossRefGoogle Scholar
  17. 17.
    Uddin GM, Youngson NA, Doyle BM, Sinclair DA, Morris MJ (2017) Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise. Sci Rep 7(1):15063. CrossRefGoogle Scholar
  18. 18.
    Cordero P, Li J, Nguyen V, Pombo J, Maicas N, Novelli M, Taylor PD, Samuelsson AM, Vinciguerra M, Oben JA (2017) Developmental programming of obesity and liver metabolism by maternal perinatal nutrition involves the melanocortin system. Nutrients 9(9):E1041. CrossRefGoogle Scholar
  19. 19.
    Fante T et al (2016) Diet-induced maternal obesity alters insulin signalling in male mice offspring rechallenged with a high-fat diet in adulthood. PLoS One 1(8):e0160184. 11) .CrossRefGoogle Scholar
  20. 20.
    de Paula Simino LA et al (2017) Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet. Nutr Metab (Lond) 14:16. CrossRefGoogle Scholar
  21. 21.
    Benatti RO et al (2014) Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring. Br J Nutr Jun 28(12):2112–2122. 111) .CrossRefGoogle Scholar
  22. 22.
    Lima NDS, Teixeira L, Gambero A, Ribeiro ML (2018) Guarana (Paullinia cupana) stimulates mitochondrial biogenesis in mice fed high-fat diet. Nutrients 31 10(2):E165. CrossRefGoogle Scholar
  23. 23.
    Bérubé-Parent S, Pelletier C, Doré J, Tremblay A (2005) Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br J Nutr 94(3):432–436CrossRefGoogle Scholar
  24. 24.
    Ruebel ML, Cotter M, Sims CR, Moutos DM, Badger TM, Cleves MA, Shankar K, Andres A (2017) Obesity modulates inflammation and lipid metabolism oocyte gene expression: a single-cell transcriptome perspective. J Clin Endocrinol Metab 102(6):2029–2038. CrossRefGoogle Scholar
  25. 25.
    Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR (2004) Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. J Parenter Enteral Nutr 28:410–415. CrossRefGoogle Scholar
  26. 26.
    Ahima RS, Saper CB, Flier JS, Elmquist JK (2000) Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21(3):263–307. CrossRefGoogle Scholar
  27. 27.
    Cos P et al (2006) Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’. J Ethnopharmacol 106(3):290–302CrossRefGoogle Scholar
  28. 28.
    Hanson M et al (2011) Developmental plasticity and developmental origins of non-communicable disease: theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol 106:272–280. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Laboratory of Immunopharmacology and Molecular Biology, Clinical Pharmacology and Gastroenterology UnitSao Francisco University Medical SchoolBraganca PaulistaBrazil

Personalised recommendations